Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

Treatment for HER2-negative metastatic breast cancer depends on factors like hormone receptor status, with chemo/immunotherapy for PD-L1-positive triple negative disease, PARP inhibitors for BRCA mutations, and antibody-drug conjugates as options after first line therapy.

Related Content:

Navigating HER2+ Metastatic Breast Cancer TreatmentBreast Cancer

Breast Cancer Survivor Advocates for Access to Scalp Cooling

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

Dealing With Peripheral Neuropathy After Breast Cancer Treatment